hJAA-F11
Cancer Imaging / Metastasis Inhibition
Pre-clinicalActive
Key Facts
About For-Robin
For-Robin is a University at Buffalo (UB) spinoff biotech advancing an antibody therapeutic, hJAA-F11, designed to prevent cancer metastasis, particularly in lung and breast cancers. Currently in late preclinical development, the company is preparing for clinical imaging trials slated for 2025-2026 with support from NCI NExT partners. The company is privately funded, having secured at least $2 million in grants, and is driven by a deeply personal mission inspired by the founder's sister.
View full company profile